Salle de presse
novembre 14, 2016
Bioventus Expands to Mexico with DUROLANE for Knee OA Patients
Bioventus Expands to Mexico with DUROLANE® for Knee Osteoarthritis Patients HOOFDDORP, THE NETHERLANDS – November 14, 2016 – Bioventus, a leader in…
novembre 7, 2016
Bioventus Appoints Andrew McCartney Managing Director, International for EMEA
Bioventus Appoints Andrew McCartney Managing Director, International for EMEA DURHAM, NC – November 7, 2016 – Bioventus, a global leader in…
septembre 19, 2016
Bioventus Launches EXOGEN in the Kingdom of Saudi Arabia
Bioventus Launches EXOGEN® Ultrasound Bone Healing System in the Kingdom of Saudi Arabia HOOFDDORP, THE NETHERLANDS – September 19, 2016 – Bioventus,…
septembre 8, 2016
Fractures That Fail to Heal May Be Predictable
Fractures That Fail to Heal May Be Predictable Based on Patient Risk Factors DURHAM, NC – September 8, 2016 – Recent research has shed light on the…
août 9, 2016
Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain
Bioventus Launches GELSYN-3™ for Treatment of Knee Osteoarthritis Pain DURHAM, NC – August 9, 2016 – Bioventus, a global leader in orthobiologic…
juillet 1, 2016
Bioventus Extends Distribution Agreement for SUPARTZ FX
Bioventus Extends Distribution Agreement for SUPARTZ FX™ DURHAM, NC – July 1, 2016 – Bioventus, a global leader in orthobiologic solutions, today…
juin 24, 2016
Michael Minogue Named to Bioventus Board of Managers
Michael Minogue Named to Bioventus Board of Managers DURHAM, NC – June 24, 2016 – Bioventus, a global leader in orthobiologic solutions, today…
avril 20, 2016
Olympic and Norwegian World Cup Medal Winning Skier Magnus Moan to Appear at NOF 2016
Olympic and Norwegian World Cup Medal Winning Skier Magnus Moan to Appear at Nordic Orthopaedic Federation Congress Will Share Fracture Healing…
mars 21, 2016
Bioventus Introduces New Products at AAOS
Bioventus Introduces New Products for Spine Surgery, Osteoarthritis at AAOS ORLANDO – March 2, 2016 – Bioventus, a leader in orthobiologic solutions,…
mars 9, 2016
Bioventus Enters Into Agreement with IBSA for Rights to GELSYN-3
Bioventus Enters Into Agreement with IBSA for Rights to GELSYN-3™ DURHAM, NC – February 23, 2016 – Bioventus, a global leader in orthobiologic…
Recherche sur les nouvelles
Requêtes médiatiques
Thomas Hill
Directeur des communications de l’entreprise
919.474.6715
[email protected]
Bibliothèque de téléchargement
Logos de l’entreprise et de la marque
Télécharger maintenant
Images du produit
Télécharger maintenant
